Publication | Open Access

A Chemically Modified Curcumin (CMC 2.24) Inhibits Nuclear Factor κB Activation and Inflammatory Bone Loss in Murine Models of LPS-Induced Experimental Periodontitis and Diabetes-Associated Natural Periodontitis

InflammationAnti-inflammatoryCmc 2.24MedicineImmunologyChronic InflammationChemically Modified CurcuminInflammatory Bone LossPharmacologyInflammatory DiseaseOxidative Stress